An observational study in Pilonidal Cyst and Sinus Without Abscess, sponsored by Zagazig University. Completed at 1 site in Egypt. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-09.
Sponsored by Zagazig University · Observational
study comparing the Karydakis and Limberg flaps
study comparing the Karydakis and Limberg flaps in management of pilonidal sinus
109 studies on the registry are indexed under Pilonidal Sinus; 32 are open to participants now.
This study's enrollment of 352 is above the median of 145 across 37 observational studies indexed under Pilonidal Sinus.
Browse Pilonidal Sinus studies →Zagazig University is the lead sponsor of 459 studies on the registry; 77 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
Counted across the registry records on this site, refreshed daily.
all patients > 18 years with PNS underwent karydakis and limberg flap
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Karadakis flap for managing pilonidal cyst
Procedure: karydakis surgery
Procedure: Limberg flap
karydakis surgery for managing pilonidal sinus
using rheumboid flap to cover the defect after pilonidal sinus excision
sexual function comparison
sexual function evaluation through questionnaire modulated by our group and asked to the patients
Time frame: 1 year
driving function evaluation
driving evaluation after surgery through questionnaire modulated by our group and asked to the patients
Time frame: 1 year
Plan to share: Yes — upon reasonable requirement
Supporting information: Study protocol, Statistical analysis plan
Ran from Jul 2017 to primary completion in Jul 2024, 84 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.